(ATEX) Anterix - Ratings and Ratios
Spectrum Licenses, Private Broadband, CatalyX Platform, Rural Broadband
ATEX EPS (Earnings per Share)
ATEX Revenue
Description: ATEX Anterix October 23, 2025
Anterix Inc. (NASDAQ: ATEX) commercializes federally-licensed 900 MHz spectrum to enable utilities and critical-infrastructure operators to build private broadband networks, offering its CatalyX ecosystem platform, security services, and rural broadband solutions.
The firm controls approximately 7 MHz of contiguous spectrum across the lower 48 states, Hawaii, Alaska, and Puerto Rico, positioning it as one of the few U.S. holders of nationwide mid-band spectrum that can support low-latency, long-range connectivity for IoT and private LTE/5G deployments.
As of the most recent filing (Q3 2024), Anterix reported annualized revenue of roughly $12 million with a year-over-year growth rate of 18 %, while its cash position stood at $45 million, giving it a runway of over three years without additional financing.
Key economic drivers for the company include the accelerating shift of utilities toward smart-grid automation, the FCC’s continued emphasis on rural broadband subsidies (e.g., the Rural Digital Opportunity Fund), and the broader enterprise demand for private 5G networks that avoid public-carrier congestion.
Given the modest market cap (~$300 million) and the high-margin nature of spectrum licensing, ATEX’s valuation is highly sensitive to the speed at which its target customers adopt private network solutions; a slowdown in utility capital-expenditure cycles would materially affect projected cash flows.
For a deeper, data-driven assessment of ATEX’s upside potential, you may find the analyst tools on ValueRay useful for modeling scenario-based outcomes.
ATEX Stock Overview
| Market Cap in USD | 360m |
| Sub-Industry | Wireless Telecommunication Services |
| IPO / Inception | 2015-02-03 |
ATEX Stock Ratings
| Growth Rating | -84.2% |
| Fundamental | 40.3% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -54.0% |
| Analyst Rating | 4.67 of 5 |
ATEX Dividends
Currently no dividends paidATEX Growth Ratios
| Growth Correlation 3m | -71.4% |
| Growth Correlation 12m | -85.5% |
| Growth Correlation 5y | -68% |
| CAGR 5y | -22.16% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.39 |
| CAGR/Mean DD 3y (Pain Ratio) | -1.07 |
| Sharpe Ratio 12m | -2.60 |
| Alpha | -63.62 |
| Beta | 0.920 |
| Volatility | 39.65% |
| Current Volume | 252.6k |
| Average Volume 20d | 167.7k |
| Stop Loss | 17 (-5.7%) |
| Signal | -0.66 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (29.3m TTM) > 0 and > 6% of Revenue (6% = 355.4k TTM) |
| FCFTA -0.08 (>2.0%) and ΔFCFTA -17.82pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 327.7% (prev 962.5%; Δ -634.8pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.08 (>3.0%) and CFO -30.0m <= Net Income 29.3m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (18.7m) change vs 12m ago 1.17% (target <= -2.0% for YES) |
| Gross Margin 92.96% (prev 84.71%; Δ 8.25pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.74% (prev 1.59%; Δ 0.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.28 (EBITDA TTM -10.5m / Interest Expense TTM -38.8m) >= 6 (WARN >= 3) |
Altman Z'' -5.39
| (A) 0.05 = (Total Current Assets 55.4m - Total Current Liabilities 35.9m) / Total Assets 359.6m |
| (B) -1.02 = Retained Earnings (Balance) -366.8m / Total Assets 359.6m |
| warn (B) unusual magnitude: -1.02 — check mapping/units |
| (C) -0.03 = EBIT TTM -11.0m / Avg Total Assets 340.4m |
| (D) -2.10 = Book Value of Equity -366.8m / Total Liabilities 174.8m |
| Total Rating: -5.39 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 40.26
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield -9.33% = -4.66 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.03 = 2.50 |
| 5. Debt/Ebitda 3.45 = -2.27 |
| 6. ROIC - WACC (= -17.01)% = -12.50 |
| 7. RoE 18.77% = 1.56 |
| 8. Rev. Trend 89.58% = 6.72 |
| 9. EPS Trend 28.14% = 1.41 |
What is the price of ATEX shares?
Over the past week, the price has changed by -8.34%, over one month by -19.40%, over three months by -13.98% and over the past year by -47.84%.
Is Anterix a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ATEX is around 12.83 USD . This means that ATEX is currently overvalued and has a potential downside of -28.84%.
Is ATEX a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ATEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.3 | 206.9% |
| Analysts Target Price | 55.3 | 206.9% |
| ValueRay Target Price | 14.4 | -20.1% |
ATEX Fundamental Data Overview November 06, 2025
P/E Trailing = 12.461
P/S = 60.705
P/B = 2.28
Beta = 0.92
Revenue TTM = 5.92m USD
EBIT TTM = -11.0m USD
EBITDA TTM = -10.5m USD
Long Term Debt = 5.20m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.53m USD (from shortTermDebt, last quarter)
Debt = 5.20m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -36.2m USD (from netDebt column, last quarter)
Enterprise Value = 323.4m USD (359.6m + Debt 5.20m - CCE 41.4m)
Interest Coverage Ratio = -0.28 (Ebit TTM -11.0m / Interest Expense TTM -38.8m)
FCF Yield = -9.33% (FCF TTM -30.2m / Enterprise Value 323.4m)
FCF Margin = -509.1% (FCF TTM -30.2m / Revenue TTM 5.92m)
Net Margin = 495.1% (Net Income TTM 29.3m / Revenue TTM 5.92m)
Gross Margin = 92.96% ((Revenue TTM 5.92m - Cost of Revenue TTM 417.0k) / Revenue TTM)
Gross Margin QoQ = 91.26% (prev 100.0%)
Tobins Q-Ratio = 0.90 (Enterprise Value 323.4m / Total Assets 359.6m)
Interest Expense / Debt = 1127 % (Interest Expense 58.6m / Debt 5.20m)
Taxrate = -9.85% (negative due to tax credits) (-2.26m / 22.9m)
NOPAT = -12.1m (EBIT -11.0m * (1 - -9.85%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.54 (Total Current Assets 55.4m / Total Current Liabilities 35.9m)
Debt / Equity = 0.03 (Debt 5.20m / totalStockholderEquity, last quarter 184.8m)
Debt / EBITDA = 3.45 (negative EBITDA) (Net Debt -36.2m / EBITDA -10.5m)
Debt / FCF = 1.20 (negative FCF - burning cash) (Net Debt -36.2m / FCF TTM -30.2m)
Total Stockholder Equity = 156.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.16% (Net Income 29.3m / Total Assets 359.6m)
RoE = 18.77% (Net Income TTM 29.3m / Total Stockholder Equity 156.3m)
RoCE = -6.81% (EBIT -11.0m / Capital Employed (Equity 156.3m + L.T.Debt 5.20m))
RoIC = -7.73% (negative operating profit) (NOPAT -12.1m / Invested Capital 156.3m)
WACC = 9.28% (E(359.6m)/V(364.8m) * Re(9.41%) + (debt cost/tax rate unavailable))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.56%
Fair Price DCF = unknown (Cash Flow -30.2m)
EPS Correlation: 28.14 | EPS CAGR: 26.34% | SUE: 0.75 | # QB: 0
Revenue Correlation: 89.58 | Revenue CAGR: 58.73% | SUE: -0.32 | # QB: 0
Additional Sources for ATEX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle